全文获取类型
收费全文 | 8723篇 |
免费 | 565篇 |
国内免费 | 57篇 |
专业分类
耳鼻咽喉 | 61篇 |
儿科学 | 201篇 |
妇产科学 | 122篇 |
基础医学 | 827篇 |
口腔科学 | 172篇 |
临床医学 | 782篇 |
内科学 | 2230篇 |
皮肤病学 | 80篇 |
神经病学 | 1183篇 |
特种医学 | 290篇 |
外科学 | 1574篇 |
综合类 | 21篇 |
一般理论 | 1篇 |
预防医学 | 355篇 |
眼科学 | 208篇 |
药学 | 460篇 |
中国医学 | 13篇 |
肿瘤学 | 765篇 |
出版年
2023年 | 110篇 |
2022年 | 178篇 |
2021年 | 396篇 |
2020年 | 230篇 |
2019年 | 303篇 |
2018年 | 313篇 |
2017年 | 237篇 |
2016年 | 272篇 |
2015年 | 285篇 |
2014年 | 412篇 |
2013年 | 497篇 |
2012年 | 766篇 |
2011年 | 713篇 |
2010年 | 364篇 |
2009年 | 364篇 |
2008年 | 545篇 |
2007年 | 530篇 |
2006年 | 547篇 |
2005年 | 451篇 |
2004年 | 410篇 |
2003年 | 360篇 |
2002年 | 310篇 |
2001年 | 63篇 |
2000年 | 53篇 |
1999年 | 62篇 |
1998年 | 41篇 |
1997年 | 39篇 |
1996年 | 47篇 |
1995年 | 28篇 |
1994年 | 34篇 |
1993年 | 30篇 |
1992年 | 40篇 |
1991年 | 39篇 |
1990年 | 21篇 |
1989年 | 35篇 |
1988年 | 19篇 |
1987年 | 15篇 |
1986年 | 20篇 |
1985年 | 17篇 |
1984年 | 27篇 |
1983年 | 17篇 |
1982年 | 13篇 |
1981年 | 17篇 |
1980年 | 8篇 |
1979年 | 12篇 |
1978年 | 5篇 |
1977年 | 5篇 |
1975年 | 5篇 |
1974年 | 10篇 |
1973年 | 5篇 |
排序方式: 共有9345条查询结果,搜索用时 15 毫秒
991.
992.
993.
Several cases of symptomatic hemicrania continua (HC) have been reported. A 66‐year‐old man, suffering from migraine without aura, presented with a four month history of a new headache fulfilling the ICHD 3beta clinical criteria for HC. HC onset was strictly related to the use of transdermal nitroglycerine patch (TNP). In agreement with the cardiologist, TNP was discontinued and the headache promptly disappeared; symptoms reappeared within 6‐12 hours after nitroglycerine reintroduction. After permanent discontinuation of TNP, headache disappeared at one year follow‐up. To the best of our knowledge, this is the first report of the occurrence of an HC‐like headache related to TNP. 相似文献
994.
Induction of immune tolerance to coagulation factor IX antigen by in vivo hepatic gene transfer
下载免费PDF全文
![点击此处可从《The Journal of clinical investigation》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Mingozzi F Liu YL Dobrzynski E Kaufhold A Liu JH Wang Y Arruda VR High KA Herzog RW 《The Journal of clinical investigation》2003,111(9):1347-1356
Gene replacement therapy is an attractive approach for treatment of genetic disease, but may be complicated by the risk of a neutralizing immune response to the therapeutic gene product. There are examples of humoral and cellular immune responses against the transgene product as well as absence of such responses, depending on vector design and the underlying mutation in the dysfunctional gene. It has been unclear, however, whether transgene expression can induce tolerance to the therapeutic antigen. Here, we demonstrate induction of immune tolerance to a secreted human coagulation factor IX (hF.IX) antigen by adeno-associated viral gene transfer to the liver. Tolerized mice showed absence of anti-hF.IX and substantially reduced in vitro T cell responses after immunization with hF.IX in adjuvant. Tolerance induction was antigen specific, affected a broad range of Th cell subsets, and was favored by higher levels of transgene expression as determined by promoter strength, vector dose, and mouse strain. Hepatocyte-derived hF.IX expression induced regulatory CD4(+) T cells that can suppress anti-hF.IX formation after adoptive transfer. With a strain-dependent rate of success, tolerance to murine F.IX was induced in mice with a large F.IX gene deletion, supporting the relevance of these data for treatment of hemophilia B and other genetic diseases. 相似文献
995.
Pérez-Vázquez M Román F Aracil B Cantón R Campos J 《Antimicrobial agents and chemotherapy》2003,47(11):3539-3541
The in vitro activity of garenoxacin (BMS-284756) against 62 clinical Haemophilus influenzae isolates with different fluoroquinolone susceptibilities was determined by the microdilution susceptibility testing method and compared with the activities of other oral quinolones and nonquinolone oral antimicrobial agents. Cefixime presented the highest intrinsic activity (MIC at which 50% of the isolates tested were inhibited [MIC(50)], 0.01 microg/ml), followed by garenoxacin, moxifloxacin, and ciprofloxacin (MIC(50), 0.06 microg/ml), levofloxacin (MIC(50), 0.12 microg/ml), cefuroxime (MIC(50), 1.0 microg/ml), and amoxicillin-clavulanate (MIC(50), 1.0/0.5 microg/ml), amoxicillin (MIC(50), 2 microg/ml), azithromycin (MIC(50), 4 microg/ml), and erythromycin (MIC(50), 8 microg/ml). In strains with ciprofloxacin MICs of < or =0.06 microg/ml, ciprofloxacin and garenoxacin displayed similar MIC(50)s and MIC(90)s, one dilution lower than those of moxifloxacin and levofloxacin. For strains for which ciprofloxacin MICs were > or = 0.12 microg/ml, MIC(50)s were similar for the four quinolones tested, although garenoxacin presented the widest activity range (0.03 to 32 microg/ml) and the highest MIC at which 90% of the isolates tested were inhibited (16.0 microg/ml). For strains without amino acid changes in the quinolone resistance determining region (QRDR) of GyrA and ParC, garenoxacin MICs were < or =0.03 microg/ml; with a single amino acid change in GyrA, garenoxacin MICs were 0.06 to 0.12 microg/ml; with one amino acid change each in GyrA and ParC, garenoxacin MICs were 0.5 to 2.0 micro g/ml; one amino acid change in ParC combined with two amino acid changes in GyrA increased the MICs to > or = 4 microg/ml for all assayed quinolones. We conclude that garenoxacin has excellent activity against H. influenzae, although progressive acquired resistance was observed by step-by-step mutation in the QRDR of gyrA and parC. 相似文献
996.
Neural correlates of the emergence of consciousness of thirst 总被引:4,自引:0,他引:4
Egan G Silk T Zamarripa F Williams J Federico P Cunnington R Carabott L Blair-West J Shade R McKinley M Farrell M Lancaster J Jackson G Fox P Denton D 《Proceedings of the National Academy of Sciences of the United States of America》2003,100(25):15241-15246
Thirst was induced by rapid i.v. infusion of hypertonic saline (0.51 M at 13.4 ml/min). Ten humans were neuroimaged by positron-emission tomography (PET) and four by functional MRI (fMRI). PET images were made 25 min after beginning infusion, when the sensation of thirst began to enter the stream of consciousness. The fMRI images were made when the maximum rate of increase of thirst occurred. The PET results showed regional cerebral blood flow changes similar to those delineated when thirst was maximal. These loci involved the phylogenetically ancient areas of the brain. fMRI showed activation in the anterior wall of the third ventricle, an area that is key in the genesis of thirst but is not an area revealed by PET imaging. Thus, this region plays as major a role in thirst for humans as for animals. Strong activations in the brain with fMRI included the anterior cingulate, parahippocampal gyrus, inferior and middle frontal gyri, insula, and cerebellum. When the subjects drank water to satiation, thirst declined immediately to baseline. A precipitate decline in intensity of activation signal occurred in the anterior cingulate area (Brodmann area 32) putatively related to consciousness of thirst. The intensity of activation in the anterior wall of the third ventricle was essentially unchanged, which is consistent with the fact that a significant time (15-20 min) would be needed before plasma Na concentration changed as a result of water absorption from the gut. 相似文献
997.
Somatostatin analogs in vitro effects in a growth hormone-releasing hormone-secreting bronchial carcinoid 总被引:3,自引:0,他引:3
Zatelli MC Maffei P Piccin D Martini C Rea F Rubello D Margutti A Culler MD Sicolo N degli Uberti EC 《The Journal of clinical endocrinology and metabolism》2005,90(4):2104-2109
A 29-yr-old woman presented with acromegaly, pituitary gland enlargement, and an isolated pulmonary mass of 3.3 cm in diameter, which displayed a very high tracer uptake after OctreoScan. Plasma GHRH levels were markedly elevated. The patient underwent left lung upper lobectomy, and histopathology disclosed a bronchial atypical carcinoid. The tissue was examined for somatostatin (SRIH) receptor subtypes (SSTRs) 1-5 expression by RT-PCR. Cultured tumor cells were treated with SRIH, lanreotide (BIM-23014), or SRIH analogs selective for SSTR2 (BIM-23120), SSTR5 (BIM-23206), or SSTR1 (BIM-23926). GHRH was measured in the medium after 6 h, and cell viability was assessed after 48 h. RT-PCR analysis showed expression of SSTR1, -2, and -5. GHRH secretion was significantly reduced by SRIH (-50%), Lan (-35%), as well as by the SSTR2, SSTR5, and SSTR1 selective agonists (-55, -75, and -20%, respectively), whereas cell viability was not affected. Our data show SSTR expression in a GHRH-secreting bronchial carcinoid and provide evidence that, in vitro, selective SSTR activation differently inhibit ectopic GHRH secretion. These findings suggest that SSTR-specific SRIH analogs may be useful in the medical therapy of GHRH-secreting bronchial carcinoids. 相似文献
998.
Effect of proton pump inhibitors and antacid therapy on 13C urea breath tests and stool test for Helicobacter pylori infection 总被引:4,自引:0,他引:4
Gatta L Vakil N Ricci C Osborn JF Tampieri A Perna F Miglioli M Vaira D 《The American journal of gastroenterology》2004,99(5):823-829
OBJECTIVE: There is uncertainty about the best method of testing patients for Helicobacter pylori (H. pylori) infection while they are taking proton pump inhibitors. The aim of this study was to determine: (i) if the decreased sensitivity of the urea breath test during proton pump inhibitor is corrected by different techniques for breath testing and (ii) if the sensitivity of stool test is decreased with the administration of proton pump inhibitors. METHODS: Prospective randomized single-blind study was performed in a tertiary care university hospital. Out of 72 H. pylori infected patients endoscoped for upper abdominal symptoms 48 were randomized to proton pump inhibitors (omeprazole 20 mg each day or esomeprazole 40 mg each day) and 24 to antacid (aluminum hydroxide 800 mg each day) for 14 days. Several breath tests (standard 75 mg (13)C-UBT with citric acid, with orange juice, a tablet breath test with 100 and 50 mg of (13)C), and a stool test were carried out. Baseline samples were collected before and after treatment. RESULTS: The baseline sensitivity for all breath tests was 100% in both groups; for stool test it was 97.8% (95% CI: 88.7-96.6) and 90% (95% CI: 69.9-97.2) in the proton pump inhibitor and antacid group, respectively. After treatment, the sensitivity of tests was significantly low (UBTs range: 77.1%-85.4%; stool test: 83%; 95% CI: 63.9-91.1), while it was unchanged in the antacid group. CONCLUSIONS: False negative breath and stool tests are equally common in patients taking proton pump inhibitors. Antacids do not impair the sensitivity of the breath tests or the stool test. 相似文献
999.
The long-term treatment of heart block 总被引:5,自引:0,他引:5
1000.
Martini F Poccia F Goletti D Carrara S Vincenti D D'Offizi G Agrati C Ippolito G Colizzi V Pucillo LP Montesano C 《The Journal of infectious diseases》2002,186(6):847-850
T cells expressing Vgamma9Vdelta2 display lytic and proliferative responses against human immunodeficiency virus (HIV)-infected cells and release antiviral soluble factors. Chronic HIV-positive patients have deep changes in the composition and function of the circulating gammadelta T cell pool that are restored by highly active antiretroviral therapy (HAART). gammadelta T cells were analyzed during the rapid plasma HIV RNA rebound in HIV-infected patients undergoing structured treatment interruption (STI). A loss in circulating Vgamma9Vdelta2 T cells was observed, indicating that acute HIV replication may influence Vgamma9Vdelta2 homeostasis. These cells were lost among CD45RA(-)CD27(-) Vgamma9Vdelta2 T cell effectors, and a significant unresponsiveness, measured as antigen-driven interferon-gamma production, was observed during STI. After HAART resumption and consequent inhibition of HIV replication, Vgamma9Vdelta2 T cell reactivity was restored both quantitatively and functionally. These observations indicate that Vgamma9Vdelta2 T cells are activated early after active HIV replication but are rapidly lost when viremia is not controlled. 相似文献